What is Asaman?
Asaman operates as a specialized entity focused on the complex landscape of comparator drug sourcing. By providing a streamlined, consultative approach to procurement, the company addresses critical gaps in clinical trial logistics and pharmaceutical research requirements. Their business model prioritizes integrity and high-touch service, allowing them to navigate the regulatory and logistical hurdles inherent in global drug sourcing. Through a commitment to flexibility and innovation, Asaman has established itself as a reliable partner for organizations requiring precise, compliant, and efficient access to pharmaceutical products for research and development purposes.
How much funding has Asaman raised?
Asaman has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Asaman
PPP
Public-Private Partnership
What's next for Asaman?
With this late-stage financing, Asaman is positioned to scale its infrastructure and deepen its service capabilities. The strategic deployment of this capital will likely focus on expanding its global sourcing network and enhancing the technological framework that supports its consultative service model. As the pharmaceutical industry faces increasing pressure for faster, more transparent clinical trial processes, Asaman is well-positioned to leverage its recent backing to capture additional market share. Future growth will likely be driven by deepening existing partnerships and optimizing the supply chain to meet the evolving demands of its diverse client base, ensuring that the company remains at the forefront of the comparator drug sourcing market.
See full Asaman company page
